Bio Medica Laboratories (BMLL)₹148.00−3.46%Pharmaceuticals
Bio Medica Laboratories is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a P/E of 11.3 against a peer median of 14.7, and ROCE of 27.3% against a peer median of 11.0%. By market cap it is #8 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gennex Laboratories | 218 | 11.2 | 11.0 | 9.2 | 0.36 | 0.0 | 173 | 21 | 16.5 | −6.8 | vs BMLL |
| Sanjivani Paranteral | 214 | 28.8 | 18.0 | 15.6 | 0.30 | 0.3 | 69 | 7 | 33.3 | 44.2 | vs BMLL |
| Kerala Ayurveda | 212 | — | −10.0 | −161.1 | 7.83 | 0.0 | 131 | −16 | 15.9 | −500.5 | vs BMLL |
| Nectar Lifesciences | 198 | — | 0.0 | −31.3 | 0.00 | 0.0 | 0 | −293 | −100.0 | — | vs BMLL |
| Achyut Healthcare | 195 | — | 1.2 | 1.0 | 0.01 | — | 12 | 0 | 381.3 | −46.2 | vs BMLL |
| Brooks Laboratories | 194 | 14.7 | 21.1 | 22.1 | 0.07 | 0.0 | 86 | 25 | −10.0 | −118.6 | vs BMLL |
| Coral Laboratories | 192 | 11.6 | 11.1 | 7.9 | 0.02 | 0.3 | 86 | 16 | −5.8 | 84.8 | vs BMLL |
| Bio Medica Laboratories | 186 | 11.3 | 27.3 | 45.1 | 1.52 | 0.0 | 43 | 12 | — | — | — |
| Oxygenta Pharmaceutical | 185 | — | −34.0 | — | — | 0.0 | 113 | −18 | 144.6 | — | vs BMLL |
| Smruthi Organics | 184 | 25.1 | 8.0 | 5.2 | 0.11 | 0.9 | 102 | 3 | 55.5 | — | vs BMLL |
| Syschem (India) | 159 | 22.4 | 16.0 | 10.2 | 0.00 | 0.0 | 572 | 11 | −0.2 | −200.0 | vs BMLL |
| Peer median | 194 | 14.7 | 11.0 | 8.6 | 0.09 | 0.0 | 86 | 7 | 16.2 | −46.2 |
Listed companies closest to Bio Medica Laboratories in Pharmaceuticals include Gennex Laboratories, Sanjivani Paranteral, Kerala Ayurveda, Nectar Lifesciences, Achyut Healthcare, Brooks Laboratories, Coral Laboratories, Oxygenta Pharmaceutical.
Gennex Laboratories, with a market cap of ₹218 Cr.
Bio Medica Laboratories trades at a P/E of 11.3; the median of its peer set is 14.7. A P/E above or below the median is a description, not a judgement on value.
Bio Medica Laboratories' return on capital employed is 27.3%, above the peer median of 11.0%.